Sign inJoin waitlistJoin the waitlist

BE

Brian Engelhardt

Hematology & Oncology

Credentials: · ·

History

Hematology and Medical Oncology
Vanderbilt University
2003–2006
Internal Medicine
2000–2003
Case Western Reserve University School of Medicine
1996–2000

Research

Prospective Study of Cardiac Events During Proteasome Inhibitor Therapy for Relapsed Multiple Myeloma
Journal of Clinical Oncology · 2019 · 160 citations
Necrotising enterocolitis is characterised by disrupted immune regulation and diminished mucosal regulatory (FOXP3)/effector (CD4, CD8) T cell ratios
Gut · 2013 · 130 citations
Prevalence and risk factors associated with development of ocular GVHD defined by NIH consensus criteria
Bone Marrow Transplantation · 2012 · 88 citations

Madan Jagasia
46 papers
Adetola Kassim
40 papers
BS
Bipin Savani
40 papers
SG
Stacey Goodman
24 papers
JG
John Greer
22 papers
WC
Wichai Chinratanalab
21 papers
Heidi Chen
16 papers · 6 as a resident
Salyka Sengsayadeth
15 papers · 4 as a fellow
MB
Michael Byrne
12 papers
FS
Friedrich Schuening
8 papers
RC
Robert Cornell
8 papers
James Crowe
6 papers

Grants

Islet Cell and ST2 Axis Dysregulation in Post-Transplant Diabetes Mellitus
National Heart, Lung, and Blood Institute · R01
Contact PI · $1.6M · Vanderbilt University Medical Center
2018–2023
Metabolic and CD4+ T Cell Dysregulation in Post-Transplant Diabetes Mellitus
National Heart, Lung, and Blood Institute · K23
Contact PI · $402.3K · Vanderbilt University Medical Center
2014–2018

Clinical trials

Finding the Cause for Post-Transplant Diabetes Mellitus After Allogeneic Hematopoietic Cell Transplant
Principal investigator · Unknown
Vanderbilt-Ingram Cancer Center
2019–2025
Predicting Development of Diabetes Mellitus in Patients Undergoing Allogeneic Stem Cell Transplant
Principal investigator · Terminated
Vanderbilt-Ingram Cancer Center
2014–2019
T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant
Principal investigator · Terminated
Vanderbilt-Ingram Cancer Center
2006–2019
Treatment of Single or Double Umbilical Cord Trans + Graft-versus-host Disease (GVHD) Prophylaxis w/ Tacrolimus & Mycophenolate Mofetil
Study chair · Terminated
Vanderbilt-Ingram Cancer Center
2005–2011